Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments

Journal of Pediatric and Adolescent Gynecology

Volumn 27, Issue 6, 2014, Pages 342-346

  Oktay, K ^a,b   Bedoschi, G ^a,b  

^a Innovation Institute for Fertility Preservation and IVF   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Fertility preservation; Germ cell tumor; Lymphocytic leukemia; Oocyte cryopreservation; Ovarian stimulation; Turner syndrome

Indexed keywords

ASPARAGINASE MACROGOL; CETRORELIX; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; INHIBIN B; LEUPRORELIN; LUTEINIZING HORMONE; MERCAPTOPURINE; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TIOGUANINE; UROFOLLITROPIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CRYOPRESERVATION; DRUG WITHDRAWAL; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FERTILITY PRESERVATION; FOLLITROPIN BLOOD LEVEL; GERM CELL TUMOR; HUMAN; IN VITRO OOCYTE MATURATION; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE; OVARIAN RESERVE; OVARY FOLLICLE; PREMATURE OVARIAN FAILURE; TREATMENT OUTCOME; TURNER SYNDROME; BLOOD; CASE REPORT; CHILD; COMPLICATION; NEOPLASMS; OVULATION INDUCTION; PRIMARY OVARIAN INSUFFICIENCY; RETROSPECTIVE STUDY;

ADOLESCENT; ANTI-MULLERIAN HORMONE; CHILD; CRYOPRESERVATION; ESTRADIOL; FEMALE; FERTILITY PRESERVATION; FOLLICLE STIMULATING HORMONE; HUMANS; NEOPLASMS; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; PRIMARY OVARIAN INSUFFICIENCY; RETROSPECTIVE STUDIES; TURNER SYNDROME;

EID: 84911905572     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2014.01.003     Document Type: Article

References (26)

1. Sonmezer M., Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004, 10:251.
2. Michaeli J., Weintraub M., Gross E., Ginosar Y., Ravitsky V., Eizenman E., Mitrani E., Lebovich M., Laufer N., Kennedy S., Revel A. Fertility preservation in girls. Obstet Gynecol Int 2012, 2012:139193. Epub 2012 Feb 16. PubMed PMID: 22496695; PubMed Central PMCID: PMC3307018. 10.1155/2012/139193.
3. Rodriguez-Wallberg K.A., Oktay K. Fertility preservation medicine: options for young adults and children with cancer. J Pediatr Hematol Oncol 2010, 32:390.
4. Reichman D.E., Davis O.K., Zaninovic N., et al. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. Fertil Steril 2012, 98:1225.
5. Oktay K., Rodriguez-Wallberg K.A., Sahin G. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure. Fertil Steril 2010, 94:753.e15.
6. Huang J.Y., Tulandi T., Holzer H., et al. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by invitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008, 89:567.
7. Oktay K., Newton H., Aubard Y., et al. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology?. Fertil Steril 1998, 69:1.
8. Newton H., Aubard Y., Rutherford A., et al. Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996, 11:1487.
9. Lau N.M., Huang J.Y., MacDonald S., et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online 2009, 18:290.
10. Bedaiwy M.A., Shahin A.Y., Falcone T. Reproductive organ transplantation: advances and controversies. Fertil Steril 2008, 90:2031.
11. Herrero L., Martinez M., Garcia-Velasco J.A. Current status of human oocyte and embryo cryopreservation. Curr Opin Obstet Gynecol 2011, 23:245.
12. Cil A.P., Bang H., Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis. Fertil Steril 2013, 100:492.
13. Wennerholm U.B., Soderstrom-Anttila V., Bergh C., et al. Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod 2009, 24:2158.
14. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013, 99:37. Practice Committees of the American Society for Reproductive Medicine, Society for Assisted Reproductive TechnologySociety for Assisted Reproductive Technology.
15. Loren A.W., Mangu P.B., Beck L.N., et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013, 31:2500. American Society of Clinical Oncology.
16. Hovatta O. Ovarian function and invitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev 2012, 9(Suppl 2):713.
17. Hadnott T.N., Gould H.N., Gharib A.M., et al. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S: National Institutes of Health experience. Fertil Steril 2011, 95:2251.
18. Purushothaman R., Lazareva O., Oktay K., et al. Markers of ovarian reserve in young girls with Turner's syndrome. Fertil Steril 2010, 94:1557.
19. Borgström B., Hreinsson J., Rasmussen C., et al. Fertility preservation in girls with turner syndrome: prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab 2009, 94:74.
20. Karnis M.F. Fertility, pregnancy, and medical management of Turner syndrome in the reproductive years. Fertil Steril 2012, 98:787.
21. Nishio S., Ushijima K., Fukui A., et al. Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary. J Obstet Gynaecol Res 2006, 32:416.
22. Parkinson C.A., Hatcher H.M., Ajithkumar T.V. Management of malignant ovarian germ cell tumors. Obstet Gynecol Surv 2011, 66:507.
23. Rossi B.V., Missmer S., Correia K.F., et al. Ovarian reserve in women treated for acute lymphocytic leukemia or acute myeloid leukemia with chemotherapy, but not stem cell transplantation. ISRN Oncol 2012, 2012:956190.
24. Oktem O., Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007, 110:2222.
25. Oktem O., Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res 2007, 67:10159.
26. Lie Fong S., Visser J.A., Welt C.K., et al. Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 2012, 97:4650.